|By PR Newswire||
|August 29, 2014 06:59 PM EDT||
DUBLIN, Ireland, August 29, 2014 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/jjj5vs/global_peptic) has announced the addition of the "Global Peptic Ulcer Drugs Market 2014-2018" report to their offering.
A peptic ulcer is an open lesion that develops on the mucosal lining of the stomach and small intestine because of the caustic effect of the gastric acids and enzymes in these organs. The symptoms of peptic ulcers are pain in the abdomen, nausea, vomiting, and bloated stomach. The major symptoms include bleeding from the ulcer, which can be life-threatening. It is detected by bloody and sticky stools, often black in color. Peptic ulcers are caused mainly by a Helicobacter pylori infection followed by the overuse of OTC NSAIDs such as Naproxen, Aspirin and Ibuprofen. Peptic ulcers can be of two types based on the site of the ulcer: gastric ulcer and duodenal ulcer.
The analysts forecast the Global Peptic Ulcer Drugs market to grow at a CAGR of 2.9 percent over the period 2013-2018.
This report covers the present scenario and the growth prospects of the Global Peptic Ulcer Drugs market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the sales of various drugs used in the treatment of peptic ulcers that are available in the market.
Key Topics Covered:
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
04. Product Profiles
05. Market Research Methodology
07. Market Landscape
08. Pipeline Portfolio
09. Market Segmentation by Class of Drugs
10. Geographical Segmentation
11. Buying Criteria
12. Market Growth Drivers
13. Drivers and their Impact
14. Market Challenges
15. Impact of Drivers and Challenges
16. Market Trends
17. Trends and their Impact
18. Vendor Landscape
19. Key Vendor Analysis
- AstraZeneca plc
- Eisai Co. Ltd.
- Daewoong Pharmaceutical Co. Ltd.
- Takeda Pharmaceutical Co. Ltd.
- Daiichi Sankyo
- Dr. Reddy's Laboratories
- Ferring Pharmaceuticals
- Horizon Pharma
- Johnson and Johnson
- Merck Sharp and Dohme
- Otsuka Holdings
- Rottapharm Madaus
- Taiho Pharmaceutical
- Zeria Pharmaceutical and Zuventus Healthcare
For more information visit http://www.researchandmarkets.com/research/jjj5vs/global_peptic
Media Contact: Laura Wood , +353-1-481-1716, [email protected]
Sep. 30, 2016 05:45 PM EDT Reads: 1,368
Sep. 30, 2016 05:30 PM EDT Reads: 686
Sep. 30, 2016 04:45 PM EDT Reads: 2,002
Sep. 30, 2016 04:45 PM EDT Reads: 5,303
Sep. 30, 2016 04:30 PM EDT Reads: 391
Sep. 30, 2016 04:30 PM EDT Reads: 1,824
Sep. 30, 2016 04:30 PM EDT Reads: 732
Sep. 30, 2016 04:00 PM EDT Reads: 3,587
Sep. 30, 2016 03:45 PM EDT Reads: 3,659
Sep. 30, 2016 03:30 PM EDT Reads: 381
Sep. 30, 2016 03:00 PM EDT Reads: 3,672
Sep. 30, 2016 03:00 PM EDT Reads: 1,247
Sep. 30, 2016 03:00 PM EDT Reads: 3,015
Sep. 30, 2016 03:00 PM EDT Reads: 1,655
Sep. 30, 2016 03:00 PM EDT Reads: 569